Navigation Links
Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56
Date:1/26/2011

ere $220.6 million compared to $203.1 million in the fourth quarter of 2009 and $206.5 million last quarter.  The sequential increase in revenue was primarily driven by the inclusion of two full months of results from our Alnwick and Porcheville sites as well as from modest improvement in our toxicology services in the fourth quarter.  Full year 2010 net revenues increased 6.1% to $840.3 million compared to $791.8 million in 2009.  

Operating income for the fourth quarter was $21.1 million and included $5.4 million in costs associated with our fourth quarter restructuring actions. Operating income, excluding these costs, was $26.6 million, compared to $22.0 million last quarter and $23.1 million in the fourth quarter of last year. Operating margins for the fourth quarter, excluding the fourth quarter restructuring actions, were 12.0% compared to 10.7% last quarter and 11.3% in the fourth quarter of 2009. Sequentially, the expansion in operating margins was driven by results from our Alnwick and Porcheville sites, and modest improvement in toxicology services, partially offset by a decline in clinical pharmacology profitability, which was again impacted by study delays.  Full year operating margins were 12.0% compared to 12.6% in the prior year.  

Late-Stage Development($ in millions)4Q104Q09ChangeFY2010FY2009ChangeNet Revenues

$ 270.9

$281.9

(3.9)%

$1,085.3

$1,075.8

0.9%Operating Income

$ 47.6

$  63.8

(25.4)%

$225.5

$254.5

(11.4)%Operating Margin %

17.6%

22.6%20.8%

23.7%Q4 Restructuring

$  (7.1)

-$(7.1)

-Q2 Cost Actions

-

-$(0.2)

-Pro Forma Operating Income

$  54.7

$  63.8

(14.2)%

$232.8

$  254.5

(8.5)%Pro Forma OM%

20.2%

22.6%21.5%

23.7%The Late-Stage Development segment includes
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
2. Covance Receives Highest Level of Phase I Accreditation
3. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call
4. Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference
5. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
6. Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
7. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
8. Covance To Present At The 20th Annual Global Healthcare Services Conference
9. Covance To Present at the Deutsche Bank 35th Annual Health Care Conference
10. Covance to Present at Goldman Sachs 31st Annual Global Healthcare Conference
11. Covance to Present at William Blair & Companys 30th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)...  (Booth #7309, North Hall) — Dicom Systems ... DCMSYS Interface WebBridge, at the 100th annual RSNA Meeting ... Chicago, Illinois . ... for medical facilities of any size, WebBridge allows any ... non-standard data (e.g. JPEG, TFF, PDF, TXT, etc.) to ...
(Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
(Date:11/26/2014)... 26, 2014  Perrigo Company plc ("Perrigo") (NYSE: ... "Quality Affordable Healthcare Products®," today announced the closing of ... sale of 6,809,210 ordinary shares at a public offering ... of the option to purchase up to an additional ... Barclays Capital Inc., as representatives of the several underwriters. ...
Breaking Medicine Technology:Dicom Systems Announces WebBridge Interface at RSNA 2014 2Hovione Files its First Investigational New Drug Application With the FDA 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4
... the Potential Utility of Modigene,s CTP Technology ... ... Va., Sept. 24 Modigene Inc. (OTC,Bulletin Board: MODG) today reported ... journal Endocrinology showing that,erythropoietin (EPO) linked to Modigene,s carboxyl terminal peptide ...
... 24 Iodine has been used as an,antimicrobial ... about molecular,iodine yet many women suffering from Fibrocystic ... may soon yield an effective,nonhormonal treatment. While ... market, all,available hormonal therapies have significant adverse events. ...
Cached Medicine Technology:Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 2Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 3Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 4Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease 2
(Date:11/28/2014)... Novatus, a leading provider of ... which provides customers with greater reporting capabilities, more ... “As we continue to evolve and grow the ... and improved performance in response to requests from ... “With the enhancements that we have made to ...
(Date:11/28/2014)... Miami's Plastic Surgery of the Face recently ... Dr. Jeffrey Epstein is excited to offer patients ... platform, the site is uniquely designed for easing viewing ... 75% of all prospective rhinoplasty patients research upcoming procedures ... on with smartphones, tablets, and laptops, as well as ...
(Date:11/28/2014)... Celebration can quickly turn to tragedy if popular turkey ... Over the last decade, more than 141 serious fires ... turkey fryers, according to the U.S. Consumer Product Safety ... who tried to deep fry the turkey indoors, which ... Arthur Sanford, a burn surgeon at Loyola University Health ...
(Date:11/28/2014)... PA (PRWEB) November 28, 2014 An inventor ... curing light on a patient’s filling and it was almost ... more ergonomic curing light," she said. , The patent-pending Access ... It eases access to areas of the mouth, as well ... promotes efficiency and safety. Easy to use and clean, it ...
(Date:11/28/2014)... 2014 UniWigs.com, a leader in the wig industry, ... to the next Monday. This promotion features: , ... items up to 70% off (no coupon code needed), ... Free shipping on orders over $49 , Visit http://www.uniwigs.com ... from Nov. 28th to Dec. 1st and the first 100 shoppers ...
Breaking Medicine News(10 mins):Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2
... cancer surgeons regularly confer with plastic surgeons prior to surgery, ... a new study led by researchers at the University of ... breast cancer treatment can vary widely ranging from small ... the type of care a woman receives when it comes ...
... ,PHOENIX, Ariz. Aug. 31, 2010 The first study ... how they affect cell growth has identified two potential anti-cancer ... Genomics Research Institute (TGen) published this month in the journal ... aggressive cancer lesions that occur most frequently in the bones ...
... exposed to violence in their community are at an increased ... asthma or any cause, according to new research from the ... violence has been linked to more symptoms in pediatric asthma ... a longitudinal study showing a connection in an adult population ...
... cancer deaths worldwide, and the prognosis is generally poor, ... one type of lung cancer, adenocarcinoma, has been increasing ... in tumor cell biology that result in a more ... tissue) that have been completely surgically removed may help ...
... Portugal: Hundreds of millions of euros are being ... consulting community pharmacists rather than going straight to their ... 1 September) at the annual conference of the International ... million was freed up in one year for other ...
... Selenium effects may vary according to individual,s characteristics. ... cancer. According to results of a study published ... Prevention , a journal of the American Association for Cancer ... cancer. "The lower the levels of selenium, the ...
Cached Medicine News:Health News:Surgeons impact whether a woman gets breast reconstruction, U-M study finds 2Health News:TGen finds therapeutic targets for rare cancer in children 2Health News:Violence in inner city neighborhoods contributes to trouble with asthma 2Health News:Tumor budding identified as predictor for unfavorable outcome in lung cancer 2Health News:Health advice from pharmacists saves hundreds of millions of euros 2Health News:Health advice from pharmacists saves hundreds of millions of euros 3Health News:Increasing selenium intake may decrease bladder cancer risk 2
The new BioZ Dx incorporates the world's most advanced impedance cardiography (ICG) technology and powerful reporting features to quickly and easily provide noninvasive hemodynamic parameters....
... Implant is an endoscopic urethral implant ... (SUI). Upon implantation, the Tegress™ Implant ... (EVOH) in a Dimethyl Sulfoxide (DMSO) ... that reinforces the integrity of the ...
... reproducible re-entry of a guidewire from the ... of a peripheral vessel., , Locate ... facilitates rapid and accurate orientation of the ... eliminates the need for additional equipment, , ...
... system is intended for the qualitative detection ... When performed according to these instructions, the ... clinical information, may aid in the determination ... diagnosis of VZV infections. This test is ...
Medicine Products: